Shionogi and Ferrer conclude a contract for the promotion in Spain of▼ Rizmoic® (naldemedine), a therapeutic agent for opioid-induced constipation
24 Jun 2019
This website uses cookies to provide you with the best experience when you visit. By using this website, you consent to our use of these cookies. You can learn more about how we use cookies and how to manage them by reading our
Cookie Policy